Qiagen Beats on Both Top and Bottom Lines

Qiagen (Nasdaq: QGEN  ) reported earnings on Jan. 30. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Qiagen beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew and GAAP earnings per share grew.

Gross margins grew, operating margins dropped, net margins expanded.

Revenue details
Qiagen booked revenue of $346.5 million. The 21 analysts polled by S&P Capital IQ anticipated revenue of $331.4 million on the same basis. GAAP reported sales were 3.6% higher than the prior-year quarter's $334.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.34. The 17 earnings estimates compiled by S&P Capital IQ predicted $0.31 per share. GAAP EPS of $0.16 for Q4 were much higher than the prior-year quarter's $0.00 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 67.1%, 230 basis points better than the prior-year quarter. Operating margin was 14.1%, 1,220 basis points worse than the prior-year quarter. Net margin was 11.1%, 1,120 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $309.7 million. On the bottom line, the average EPS estimate is $0.25.

Next year's average estimate for revenue is $1.32 billion. The average EPS estimate is $1.15.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 110 members out of 121 rating the stock outperform, and 11 members rating it underperform. Among 42 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 39 give Qiagen a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Qiagen is hold, with an average price target of $18.41.

Looking for alternatives to Qiagen? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.

• Add Qiagen to My Watchlist.